You are here

Rani Therapeutics

Rani and Sangamo jettison staff, offices and assets to keep businesses afloat next year

Fierce Biotech

Thu, 11/2/23 - 11:32 am

Rani Therapeutics

Sangamo Therapeutics

This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More

Motley Fool, clinical trials,

Mon, 10/4/21 - 10:37 am

Rani Therapeutics

Six more biotechs price public debuts just before the start of the weekend

Endpoints

Fri, 07/30/21 - 12:15 pm

Tenaya Therapeutics

Rani Therapeutics

Omega Therapeutics

Rani gets financial backing to the tune of US$69m as it looks to bring injectable biologics the oral route

Biopharma Reporter

Thu, 12/10/20 - 07:21 pm

Rani Therapeutics

Rani Therapeutics eyes potential IPO as robotic pill technology takes shape

Endpoints

Thu, 01/30/20 - 10:40 am

Rani Therapeutics

Robotic pill tech found to be safe, tolerable in early human study, paving ground for oral biologics

Endpoints

Thu, 02/28/19 - 11:11 am

Rani Therapeutics

Could Oral Biosimilars of Humira and Embrel Disrupt the Biologics Market?

Xtalks

Wed, 04/25/18 - 10:23 pm

Rani Therapeutics

Novartis digs into health tech with bet on "robotic pill"

Yahoo/Reuters

Wed, 05/27/15 - 09:27 am

Rani Therapeutics